Literature DB >> 23242464

The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis.

M H Rozenbaum1, P Pechlivanoglou, T S van der Werf, J R Lo-Ten-Foe, M J Postma, E Hak.   

Abstract

The primary objective of this meta-analysis was to estimate the prevalence of adult community-acquired pneumonia (CAP) caused by Streptococcus pneumoniae in Europe, adjusted for possible independent covariates. Two reviewers conducted a systematic literature search using PubMed on English-language articles that involved human subjects with CAP during the period from January 1990 to November 2011 across European countries. A mixed-effects meta-regression model was developed and populated with 24,410 patients obtained from 77 articles that met the inclusion criteria. The model showed that the observed prevalence of S. pneumoniae in CAP significantly varies between European regions, even after adjusting for explanatory covariates, including patient characteristics, diagnostic tests, antibiotic resistance, and health-care setting. The probability of detecting S. pneumoniae was substantially higher in studies that performed more frequently a diagnostic polymerase chain reaction assay compared to all the other diagnostic tests included. Furthermore, S. pneumoniae was more likely to be confirmed as the cause of a CAP in studies with intensive care unit patients as compared to those with hospital- or community-treated patients. This study provides estimates of the average observed prevalence of S. pneumoniae, which could be used for projecting the health and economic benefits of pneumococcal immunization.

Entities:  

Mesh:

Year:  2012        PMID: 23242464     DOI: 10.1007/s10096-012-1778-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  93 in total

1.  Clinical aspects and prognostic factors in elderly patients hospitalised for community-acquired pneumonia.

Authors:  M A García-Ordóñez; J M García-Jiménez; F Páez; F Alvarez; B Poyato; M Franquelo; J D Colmenero; C Juárez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-01       Impact factor: 3.267

2.  Community-acquired pneumonia in the elderly: Spanish multicentre study.

Authors:  R Zalacain; A Torres; R Celis; J Blanquer; J Aspa; L Esteban; R Menéndez; R Blanquer; L Borderías
Journal:  Eur Respir J       Date:  2003-02       Impact factor: 16.671

3.  The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens.

Authors:  Félix Gutiérrez; Mar Masiá; Carlos Mirete; Bernardo Soldán; J Carlos Rodríguez; Sergio Padilla; Ildefonso Hernández; Gloria Royo; Alberto Martin-Hidalgo
Journal:  J Infect       Date:  2006-01-10       Impact factor: 6.072

4.  Microbial aetiology of community-acquired pneumonia in hospitalised patients.

Authors:  M Socan; N Marinic-Fiser; A Kraigher; A Kotnik; M Logar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-11       Impact factor: 3.267

5.  Routine use of the Pneumonia Severity Index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter, prospective, observational, controlled cohort study.

Authors:  Bertrand Renaud; Eva Coma; Jose Labarere; Jan Hayon; Pierre-Marie Roy; Hélène Boureaux; Fabienne Moritz; Jean François Cibien; Thomas Guérin; Emmanuel Carré; Armelle Lafontaine; Marie Pierre Bertrand; Aline Santin; Christian Brun-Buisson; Michael J Fine; Eric Roupie
Journal:  Clin Infect Dis       Date:  2006-11-28       Impact factor: 9.079

6.  Clinical evaluation of the management of community-acquired pneumonia by general practitioners in France.

Authors:  B Fantin; J P Aubert; P Unger; H Lecoeur; C Carbon
Journal:  Chest       Date:  2001-07       Impact factor: 9.410

7.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.

Authors:  Herman Goossens; Matus Ferech; Robert Vander Stichele; Monique Elseviers
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

8.  Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization.

Authors:  José Manuel Querol-Ribelles; José María Tenías; José Manuel Querol-Borrás; Teodoro Labrador; Angel Nieto; Damiana González-Granda; Isidoro Martínez
Journal:  Int J Antimicrob Agents       Date:  2005-01       Impact factor: 5.283

9.  A hospital study of community acquired pneumonia in the elderly.

Authors:  P Venkatesan; J Gladman; J T Macfarlane; D Barer; P Berman; W Kinnear; R G Finch
Journal:  Thorax       Date:  1990-04       Impact factor: 9.139

10.  Community-acquired pneumonia in older patients.

Authors:  J P Janssens; L Gauthey; F Herrmann; L Tkatch; J P Michel
Journal:  J Am Geriatr Soc       Date:  1996-05       Impact factor: 5.562

View more
  29 in total

1.  Response to the conjugate pneumococcal vaccine (PCV13) in patients with chronic lymphocytic leukemia (CLL).

Authors:  Francesca Romana Mauro; Diana Giannarelli; Clementina Maria Galluzzo; Candida Vitale; Andrea Visentin; Costantino Riemma; Serena Rosati; Marika Porrazzo; Sara Pepe; Marta Coscia; Livio Trentin; Massimo Gentile; Sara Raponi; Alessandra Micozzi; Giuseppe Gentile; Silvia Baroncelli
Journal:  Leukemia       Date:  2020-06-17       Impact factor: 11.528

2.  Pneumococcal vaccination coverage in France by general practitioners in adults with a high risk of pneumococcal disease.

Authors:  Aude Kopp; Olivier Mangin; Laurène Gantzer; Béranger Lekens; Guy Simoneau; Manoro Ravelomanantsoa; John Evans; Jean-François Bergmann; Pierre Sellier
Journal:  Hum Vaccin Immunother       Date:  2020-05-19       Impact factor: 3.452

3.  Molecular Characterization of Predominant Serotypes, Drug Resistance, and Virulence Genes of Streptococcus pneumoniae Isolates From East China.

Authors:  Li-Dan Huang; Mei-Juan Yang; Yan-Ying Huang; Ke-Yi Jiang; Jie Yan; Ai-Hua Sun
Journal:  Front Microbiol       Date:  2022-06-01       Impact factor: 6.064

4.  Trends in pathogens among patients hospitalized for pneumonia from 1993 to 2011.

Authors:  Sean B Smith; Gregory W Ruhnke; Curtis H Weiss; Grant W Waterer; Richard G Wunderink
Journal:  JAMA Intern Med       Date:  2014-11       Impact factor: 21.873

5.  Burden of pneumococcal disease among adults in Southern Europe (Spain, Portugal, Italy, and Greece): a systematic review and meta-analysis.

Authors:  Adoración Navarro-Torné; Eva Agostina Montuori; Vasiliki Kossyvaki; Cristina Méndez
Journal:  Hum Vaccin Immunother       Date:  2021-06-09       Impact factor: 4.526

6.  Rates of pneumonia among children and adults with chronic medical conditions in Germany.

Authors:  Stephen I Pelton; Kimberly M Shea; Raymond A Farkouh; David R Strutton; Sebastian Braun; Christian Jacob; Rogier Klok; Elana S Gruen; Derek Weycker
Journal:  BMC Infect Dis       Date:  2015-10-30       Impact factor: 3.090

7.  Detection and serotyping of pneumococci in community acquired pneumonia patients without culture using blood and urine samples.

Authors:  Karin Elberse; Suzan van Mens; Amelieke J Cremers; Sabine C A Meijvis; Bart Vlaminckx; Marien I de Jonge; Jacques F Meis; Cornelis Blauwendraat; Ingrid van de Pol; Leo M Schouls
Journal:  BMC Infect Dis       Date:  2015-02-13       Impact factor: 3.090

8.  Evaluation of the rapid immunochromatographic ODK0501 assay for Streptococcus pneumoniae antigen detection with nasopharyngeal swabs: preliminary report.

Authors:  Shoji Suzuki; Naoki Nishimura; Torahiko Jinta; Yasuhiko Yamano; Genta Ishikawa; Yutaka Tomishima; Noboru Uchiyama; Naohiko Chohnabayashi
Journal:  Multidiscip Respir Med       Date:  2016-06-20

Review 9.  The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review.

Authors:  A Torres; F Blasi; W E Peetermans; G Viegi; T Welte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-15       Impact factor: 3.267

Review 10.  Efficacy of PPV23 in Preventing Pneumococcal Pneumonia in Adults at Increased Risk--A Systematic Review and Meta-Analysis.

Authors:  Julia Schiffner-Rohe; Annika Witt; Jana Hemmerling; Christof von Eiff; Friedrich-Wilhelm Leverkus
Journal:  PLoS One       Date:  2016-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.